在实验性严重急性呼吸综合征冠状病毒2感染模型中用髓系细胞靶向PET示踪剂无创监测炎症过程
本研究在6只实验感染SARS-CoV-2的食蟹猴中,用64Cu标记的SIRPα纳米抗体PET/CT监测髓系细胞分布,并与TSPO靶向18F-F-DPA714对比。结果显示感染后3天纵隔淋巴结摄取增高而肺部病灶无增高,脾和骨髓摄取在感染后3周和7周更明显,提示该示踪剂可用于定量监测髓系细胞亚群分布。
要点
- 64Cu-SIRPα-Nb PET/CT在感染后3天显示所有动物纵隔淋巴结摄取增高,但肺部病灶无增高。
- 18F-F-DPA714 PET/CT显示解剖学受累和未受累肺组织摄取均增高。
- 所有动物脾和骨髓的64Cu-SIRPα-Nb摄取在感染后3周和7周更明显,且存在个体差异。
核心结论
- 研究表明64Cu-SIRPα-Nb可用于定量监测SARS-CoV-2感染期间髓系细胞亚群在全身的分布、时间分布和积聚动态,即使在中度炎症组织和受累淋巴器官中也可监测。
研究设计与样本
- 6只食蟹猴(Macaca fascicularis)实验感染SARS-CoV-2后监测7周。
- 感染前进行基线64Cu-Cu-SIRPα-Nb PET/CT,感染后第3、10、24和52天重复PET/CT,覆盖头、胸和腹部区域。
- 6只猴中3只在基线和感染后第2、9、23和51天额外进行TSPO靶向18F-F-DPA714 PET/CT检查。
主要发现
- 气管和鼻拭子subgenomic SARS-CoV-2 messenger RNA检测确认所有动物病毒感染。
- CT扫描在感染后2天发现初始肺部病变。
- 64Cu-Cu-SIRPα-Nb PET/CT显示感染后3天所有动物纵隔淋巴结示踪剂摄取增高,但肺部病灶无增高。
- 18F-F-DPA714 PET/CT显示解剖学受累和未受累肺组织摄取均增高。
- 所有动物脾和骨髓的64Cu-Cu-SIRPα-Nb摄取在感染后3周和7周更明显,骨髓和脾摄取存在个体差异,而18F-F-DPA714摄取模式较均匀。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Monitoring the presence and distribution of distinct immune cell populations is key in deciphering immunopathologic disease mechanisms. Considering the crucial role of myeloid cells in provoking hyperinflammatory responses associated with coronavirus disease 2019, a camelid-derived single-domain antibody specifically recognizing human signal-regulatory protein-α (SIRPα) as a biomarker for myeloid cells has been generated and radiolabeled with 64Cu, that is, [64Cu]copper-SIRPα-nanobody ([64Cu]Cu-SIRPα-Nb), for in vivo PET imaging. In this study, this PET tracer was used and validated to monitor the temporal dynamics of inflammatory processes during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in nonhuman primates. For further validation, the signal of [64Cu]Cu-SIRPα-Nb was compared with the signal of TSPO-targeting [18F]fluorine-N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5a]pyrimidin-3-yl)acetamide ([18F]F-DPA714). Methods: Six cynomolgus macaques (Macaca fascicularis) were experimentally infected with SARS-CoV-2 and subsequently monitored for 7 wk. We performed a baseline [64Cu]Cu-SIRPα-Nb PET/CT before infection, followed by repetitive PET/CT on days 3, 10, 24, and 52 after infection covering the head, thorax, and abdominal region. Of the 6 macaques, 3 underwent additional TSPO-targeting [18F]F-DPA714 PET/CT investigations at baseline and at days 2, 9, 23, and 51 after infection. Tracheal and nasal swabs were taken to monitor the course of infection, and changes in blood count and inflammatory mediators in the periphery blood were monitored. Results: Detection of subgenomic SARS-CoV-2 messenger RNA from tracheal and nasal swab samples confirmed viral infection of all animals. CT scans identified initial pulmonary lesions 2 days after infection. [64Cu]Cu-SIRPα-Nb PET/CT revealed increased tracer uptake in the mediastinal lymph nodes of all animals, but not in the lung lesions, 3 days after infection. [18F]F-DPA714 PET/CT showed increased uptake in both anatomically affected and unaffected lung tissues. The increased [64Cu]Cu-SIRPα-Nb uptake in the spleen and bone marrow of all animals was more pronounced 3 and 7 wk after infection. We detected individual differences in [64Cu]Cu-SIRPα-Nb uptake within the bone marrow and spleen, whereas [18F]F-DPA714 exhibited rather homogeneous uptake patterns. Conclusion: Our findings indicate that [64Cu]Cu-SIRPα-Nb is a versatile tool for quantitative monitoring of whole-body distribution, temporal distribution, and accumulation dynamics of myeloid cell subpopulations even in moderately inflamed tissues and affected lymphatic organs during SARS-CoV-2 infection.
引用
- Stammes MA, Koopman G, Wagner TR, et al. Noninvasive Monitoring of Inflammatory Processes by Myeloid Cell-Directed PET Tracers in an Experimental Severe Acute Respiratory Syndrome Coronavirus 2 Infection Model. J Nucl Med. 2026. PMID: 40876955. doi:10.2967/jnumed.125.269721
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。